HOB Net Income From Continuing Ops from 2010 to 2025

688656 Stock   95.13  1.87  2.01%   
HOB Biotech's Net Income From Continuing Ops is decreasing over the years with slightly volatile fluctuation. Overall, Net Income From Continuing Ops is expected to go to about 47.3 M this year. From 2010 to 2025 HOB Biotech Net Income From Continuing Ops quarterly data regression line had arithmetic mean of  60,004,803 and r-squared of  0.25. View All Fundamentals
 
Net Income From Continuing Ops  
First Reported
2010-12-31
Previous Quarter
42.6 M
Current Value
47.3 M
Quarterly Volatility
11 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check HOB Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HOB Biotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 40.2 M, Interest Expense of 1.9 M or Selling General Administrative of 49.5 M, as well as many indicators such as . HOB financial statements analysis is a perfect complement when working with HOB Biotech Valuation or Volatility modules.
  
This module can also supplement various HOB Biotech Technical models . Check out the analysis of HOB Biotech Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in HOB Stock

HOB Biotech financial ratios help investors to determine whether HOB Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HOB with respect to the benefits of owning HOB Biotech security.